Skip to main content

Advertisement

SpringerLink
Log in

Trisomy 11: prevalence among 22 403 unique patient cytogenetic studies and clinical correlates

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Primary, single, autosomal trisomies associated with haematological disorders. Leuk Res 1992; 16: 841–851.

  2. Heinonen K, Mrozek K, Lawrence D, Arthur DC, Pettenati MJ, Stamberg J et al. Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study. Br J Haematol 1998; 101: 513–520.

    Article  CAS  Google Scholar 

  3. Wang SA, Jabbar K, Lu G, Chen SS, Galili N, Vega F et al. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features. Leukemia, (in press).

  4. Tefferi A, Vardiman JW . Myelodysplastic syndromes. N Engl J Med 2009; 361: 1872–1885.

    Article  CAS  Google Scholar 

  5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.

    CAS  PubMed  Google Scholar 

  6. Rege-Cambrin G, Giugliano E, Michaux L, Stul M, Scaravaglio P, Serra A et al. Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes. Haematologica 2005; 90: 262–264.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra ed UO di Ematologia, Policlinico Universitario di Palermo, Palermo, Italy

    D Caramazza & S Siragusa

  2. Division of Cytogenetics, Mayo Clinic, Rochester, MN, USA

    R P Ketterling, R A Knudson & A Tefferi

  3. Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA

    R P Ketterling & R A Knudson

  4. Division of Hematopathology, Mayo Clinic, Rochester, MN, USA

    C A Hanson

  5. Division of Hematology, Mayo Clinic, Rochester, MN, USA

    A Pardanani

  6. Department of Medicine, Mayo Clinic, Rochester, MN, USA

    A Pardanani

Authors
  1. D Caramazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R P Ketterling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R A Knudson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C A Hanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Siragusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Pardanani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Tefferi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caramazza, D., Ketterling, R., Knudson, R. et al. Trisomy 11: prevalence among 22 403 unique patient cytogenetic studies and clinical correlates. Leukemia 24, 1092–1094 (2010). https://doi.org/10.1038/leu.2010.51

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.51

  • Springer Nature Limited

This article is cited by

Search

Navigation